Going viral to target tumors

(Ludwig Institute for Cancer Research) A Ludwig Cancer Research study suggests that the clinical efficacy of checkpoint blockade, a powerful new strategy to harness the immune response to treat cancers, might be dramatically improved if combined with oncolytic virotherapy, an investigational intervention that employs viruses to destroy tumors.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news